Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-05-22

FDA Approved: COLESTID — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

The FDA approved a supplemental labeling application for COLESTID (colestipol hydrochloride) submitted by Pharmacia & Upjohn Company LLC to update the drug's la…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLESTID (Colestipol hydrochloride)

Snippet

SUPPL AP for COLESTID (COLESTIPOL HYDROCHLORIDE)